This study has strengths and limitations Participants interviewe

This study has strengths and limitations. Participants interviewed were from a range of backgrounds and data saturation was achieved. Some participants had already worked in multidisciplinary

teams, thus offering a richness and diversity of views. Two GPs had previous experience working within pharmacy (one as a pharmacist, the other as a sales assistant). It may be that participants interviewed had a pre-existing interest in this topic; however, they expressed varying views, highlighting the complex and divisive nature of the subject. The majority of pharmacists interviewed were consultant pharmacists, accredited to undertake collaborative medicines management reviews. We believed that consultant Ibrutinib manufacturer pharmacists would be the most suitable candidates for a role in general practice

given their additional training and existing working relationship with GPs, and thus they were approached for this study. Although this may have introduced selection bias, the pharmacists interviewed had experience in multiple other roles within the profession, including traditional roles in community and hospital pharmacy, and thus were able to offer insights from different perspectives. The interviewer was a registered pharmacist but took care to remain neutral throughout the interview, this website and did not emphasise the fact he was a pharmacist. Being a qualitative study, caution

should be exercised in generalising these results because of the non-probabilistic nature of the sample. Although this study explored the views of GPs and pharmacists, input from other stakeholders such as consumers and major professional organisations is critical before recommending any changes to the current model. Studies in other counties have shown that integrated pharmacists have been Protirelin perceived by stakeholders to benefit both practice staff and pharmacists.[20, 21] Our study revealed some concerns about potential negative impacts of the role on the community pharmacist. Some GPs felt this new role may undermine the current role of the community pharmacist, possibly reflecting the positive relationship between these GPs and their local pharmacists; however, most pharmacists in our study, including those working within community pharmacy, felt the role would be beneficial to the pharmacy profession overall. The opinion that a non-dispensing, co-located practice pharmacist was more credible than a community pharmacist is a view shared by GPs in the UK.[22] Similarly to other studies, the GPs interviewed in our study felt that pharmacists mainly have a role in support and advisory functions.[14] Pharmacist participants, however, felt that role expansion and greater clinical involvement would be desirable and these views are reflected in the international literature.

Comments are closed.